Literature DB >> 30891769

Allergic contact dermatitis caused by synthetic rubber gloves in healthcare workers: Sensitization to 1,3-diphenylguanidine is common.

Guillaume Dejonckheere1, Anne Herman1, Marie Baeck1.   

Abstract

BACKGROUND: The frequency of allergic contact dermatitis has significantly increased in healthcare workers since the transition from latex to synthetic rubber gloves, with 1,3-diphenylguanidine being identified as the most frequently implicated allergen.
OBJECTIVES: To highlight the role of 1,3-diphenylguanidine as the culprit allergen in contact allergies to synthetic rubber gloves, to propose recommendations for patch testing, and to discuss alternatives for sensitized subjects.
MATERIALS AND METHODS: Patch test data from healthcare workers who developed hand dermatitis after wearing rubber gloves and who reacted positively to glove samples and rubber additives were collected from September 2010 to December 2017 in a Belgian hospital.
RESULTS: A total of 44 caregivers were included in this study. Patch tests showed that: (a) 84% of the study population reacted positively to carba mix; (b) 86% reacted positively to 1,3-diphenylguanidine; and (c) 13 (30%) reacted positively to thiuram mix. Half of the subjects reacted positively to gloves containing 1,3-diphenylguanidine, whereas none reacted to accelerator-free gloves.
CONCLUSION: The most commonly identified allergen was 1,3-diphenylguanidine, far ahead of thiurams, which were previously described as the most sensitizing accelerators. The use of 1,3-diphenylguanidine-free gloves is recommended. No subject reacted to gloves without accelerators, thus confirming their efficiency among accelerator-sensitized patients. We recommend that 1,3-diphenylguanidine be added to the European baseline series.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  1,3-diphenylguanidine; allergic contact dermatitis; healthcare workers; rubber accelerators; rubber gloves; thiuram

Mesh:

Substances:

Year:  2019        PMID: 30891769     DOI: 10.1111/cod.13269

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN: 0105-1873            Impact factor:   6.600


  4 in total

Review 1.  Position statement: The need for EU legislation to require disclosure and labelling of the composition of medical devices.

Authors:  A Herman; W Uter; T Rustemeyer; M Matura; K Aalto-Korte; J Duus Johansen; M Gonçalo; I R White; A Balato; A M Giménez Arnau; K Brockow; C G Mortz; V Mahler; A Goossens
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-05-06       Impact factor: 6.166

Review 2.  Contact Allergy-Emerging Allergens and Public Health Impact.

Authors:  Wolfgang Uter; Thomas Werfel; Jean-Pierre Lepoittevin; Ian R White
Journal:  Int J Environ Res Public Health       Date:  2020-04-01       Impact factor: 3.390

Review 3.  What Is New in Occupational Allergic Contact Dermatitis in the Year of the COVID Pandemic?

Authors:  Erica B Lee; Marissa Lobl; Aubree Ford; Vincent DeLeo; Brandon L Adler; Ashley Wysong
Journal:  Curr Allergy Asthma Rep       Date:  2021-03-29       Impact factor: 4.806

4.  Onset of occupational hand eczema among healthcare workers during the SARS-CoV-2 pandemic: Comparing a single surgical site with a COVID-19 intensive care unit.

Authors:  Anne Guertler; Nicholas Moellhoff; Thilo L Schenck; Christine S Hagen; Benjamin Kendziora; Riccardo E Giunta; Lars E French; Markus Reinholz
Journal:  Contact Dermatitis       Date:  2020-06-16       Impact factor: 6.419

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.